Tresiba(R) Demonstrated Significantly Improved Blood Sugar Con...
ORLANDO, Florida, June 24, 2018 /PRNewswire-AsiaNet/ -- Adults with type 2 diabetes treated with Tresiba(R) (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulinFindings from CONFIRM - a large real-worl...